If signed into law, the Main Street Pharmacy Access Act will not arrive as the sweeping, all-encompassing provider-status bill some in the pharmacy profession had envisioned. Experts explain, however, ...
Vaccination and natural infection both train the immune system, but only one route carries the added risk of long COVID and ...
COVID-19 vaccine resistance has shifted from acute ideological opposition toward broader apathy, a trend now spilling into ...
Data show that commercially and Medicaid-insured children with chronic or immunocompromising conditions incur 2- to 3-fold higher costs. A retrospective cohort study using the Merative MarketScan ...
Eligibility required diary-confirmed perimenstrual attacks in ≥2 of 3 cycles and excluded chronic migraine and certain aura syndromes, strengthening interpretability for episodic menstrual patterns.
AD109 produced statistically significant AHI improvement versus placebo at 26 weeks (treatment difference –4.0 events/hour; ...
Johnson & Johnson now requires comprehensive pharmacy/medical claims elements to be submitted to its 340B ESP platform, with suspension of all 340B pricing within five business days after repeated ...
Cox-adjusted analyses associated ≥1 year HRT use with reduced all-cause dementia (HR 0.90) and Alzheimer disease (HR 0.84), ...
Vanessa Slowey lays the ground for where AI and automation are impacting pharmacy practice today and discusses what ...
FDA approved 40-mg and 50-mg BID leniolisib for APDS in children 4–11 years weighing ≥27 kg, representing the first ...
Advanced respiratory support during acute hospitalization demonstrated the strongest pooled association with post-COVID-19 ...
National claims data (>104 million adults) showed higher unadjusted GLP-1 use in SMI, but adjustment for indications and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results